Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor

We administered recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) to four patients with myelodysplastic syndrome (MDS) and three patients with non‐MDS (two malignant lymphoma and one lung cancer) as a part of a phase II trial and analyzed the effects of rhG‐CSF on the neoplastic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohyashiki, Kazuma, Ohyashiki, Junko H., Toyama, Keisuke, Takaku, Fumimaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917852/
https://www.ncbi.nlm.nih.gov/pubmed/2480943
http://dx.doi.org/10.1111/j.1349-7006.1989.tb01725.x